Search results
Results From The WOW.Com Content Network
The PMPRB is an independent federal quasi-judicial body established through Section 91 of the Patent Act. [7] Sections 79 through to 103 of the Act set out the mandate, structure, appointment process, and jurisdiction of the Board. The objective of the board is to preventing manufacturers of patented medicines from charging excessive prices. [8]
The Food and Drugs Act prohibits most direct-to-consumer advertising of prescription medications: all direct-to-consumer advertising of drugs was forbidden until 1978, when Health Canada began to allow ads containing names, quantities, and prices only, so that pharmacies could display their prices for comparison purposes. [10]
Canada's Drug Agency. Canada's Drug Agency ( CDA; French: L’Agence des médicaments du Canada, AMC) is a pan-Canadian health organization responsible for coordinating and aligning drug policy across provinces and territories. The CDA provides Canada 's various healthcare organizations with evidence-based advice, allowing them to make informed ...
Around 25% of India's drugs are fake, counterfeit or substandard. If the fake drugs market grows at the current rate of 25%, it will cross US$10 billion mark by 2017. Trade in fake drugs is driven caused by lack of adequate regulations, shortage of drug inspectors and a lack of lab facilities to check the purity of drugs.
The plan to allow Florida to import cheaper prescription drugs from Canada is already facing outrage from Canadians who claim it could make their own drug supply shortages worse.
The Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals, more commonly known by its abbreviation CPS, [ 1] is a reference book that contains drug monographs and numerous features which help healthcare professionals prescribe and use drugs safely and appropriately.
A major factor for unaffordable healthcare costs has been skyrocketing drug prices, unchecked by a lack of competition. In Kentucky, three factors were present in 2004: Large numbers of ...
The Controlled Drugs and Substances Act (French: Loi réglementant certaines drogues et autres substances) is Canada's federal drug control statute. Passed in 1996 under Prime Minister Jean Chrétien's government, it repeals the Narcotic Control Act and Parts III and IV of the Food and Drugs Act, and establishes eight Schedules of controlled substances and two Classes of precursors.